Deanna Langfitt

1.1k total citations
15 papers, 315 citations indexed

About

Deanna Langfitt is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Deanna Langfitt has authored 15 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Deanna Langfitt's work include CAR-T cell therapy research (11 papers), CRISPR and Genetic Engineering (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Deanna Langfitt is often cited by papers focused on CAR-T cell therapy research (11 papers), CRISPR and Genetic Engineering (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Deanna Langfitt collaborates with scholars based in United States, Italy and Egypt. Deanna Langfitt's co-authors include Stephen Gottschalk, Sagar L. Patil, Matthew Bell, Giedre Krenciute, Mireya Paulina Velasquez, Jeffery M. Klco, Abishek Vaidya, Jean‐Yves Métais, Michael M. Meagher and Timothy Lockey and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Deanna Langfitt

14 papers receiving 313 citations

Peers

Deanna Langfitt

ONCOL

IMMUN

GENET

Zhen Jin China

Anat Globerson Levin Israel

Rebecca Epperly United States

Daosheng Huang China

Chengfei Pu China

Sagar L. Patil United States

Dennis Christoph Harrer Germany

Reyisa Bughda United Kingdom

Carla A. Jaeger-Ruckstuhl United States

Tianning Gu China

Zhen Jin China

Deanna Langfitt

177 ×0.7

ONCOL

117 ×1.0

65 ×0.6

IMMUN

134 ×1.8

59 ×0.8

GENET

Citations per year, relative to Deanna Langfitt Deanna Langfitt (= 1×) peers Zhen Jin

Countries citing papers authored by Deanna Langfitt

Since Specialization

Citations

This map shows the geographic impact of Deanna Langfitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deanna Langfitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deanna Langfitt more than expected).

Fields of papers citing papers by Deanna Langfitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deanna Langfitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deanna Langfitt. The network helps show where Deanna Langfitt may publish in the future.

Co-authorship network of co-authors of Deanna Langfitt

This figure shows the co-authorship network connecting the top 25 collaborators of Deanna Langfitt. A scholar is included among the top collaborators of Deanna Langfitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deanna Langfitt. Deanna Langfitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Perry, Scott, David C. Brice, Ahmed Kandeil, et al.. (2025). Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cells. Journal of Virology. 99(2). e0146024–e0146024.

Wickman, Elizabeth, Shannon Lange, Jessica Wagner, et al.. (2024). IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors. Journal for ImmunoTherapy of Cancer. 12(11). e009743–e009743. 9 indexed citations

Lowe, Brandon R., Jordan A. Beard, Matthew M. Wielgosz, et al.. (2024). Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector production. Molecular Therapy — Methods & Clinical Development. 32(2). 101270–101270. 3 indexed citations

Zoine, Jaquelyn T., Jorge Ibañez-Vega, Liqing Tian, et al.. (2024). Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificity. Cell Reports Medicine. 5(2). 101422–101422. 14 indexed citations

Smith, Kyle, Deanna Langfitt, Stephen Gottschalk, et al.. (2024). Abstract PR014: Robust disease monitoring using CSF liquid biopsies collected from children undergoing cellular therapy for malignant central nervous system tumors. Clinical Cancer Research. 30(21_Supplement). PR014–PR014. 1 indexed citations

Haydar, Dalia, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.. (2023). CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity. Cancer Research Communications. 3(12). 2430–2446. 10 indexed citations

Zoine, Jaquelyn T., Jeremy Chase Crawford, Abishek Vaidya, et al.. (2022). Engineering naturally occurring CD7− T cells for the immunotherapy of hematological malignancies. Blood. 140(25). 2684–2696. 43 indexed citations

Hebbar, Nikhil, Rebecca Epperly, Abishek Vaidya, et al.. (2022). CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nature Communications. 13(1). 587–587. 66 indexed citations

Zoine, Jaquelyn T., Jeremy Chase Crawford, Deanna Langfitt, et al.. (2022). Establishing Immunocompetent Leukemia Models to Investigate the Impact of CAR T Cells on the Immune Microenvironment and Bone Marrow Niche. Blood. 140(Supplement 1). 7376–7377. 1 indexed citations

10.

Bell, Matthew, et al.. (2021). A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell Function. Cancer Discovery. 11(7). 1661–1671. 47 indexed citations

11.

Zebley, Caitlin C., Charmaine Brown, Mi Tian, et al.. (2021). CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia. Cell Reports. 37(9). 110079–110079. 76 indexed citations

12.

Wagner, Jessica, Elizabeth Wickman, Timothy I. Shaw, et al.. (2020). Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin. Cancer Immunology Research. 9(3). 279–290. 36 indexed citations

13.

Zebley, Caitlin C., Christopher T. Petersen, Brooke Prinzing, et al.. (2020). De novo DNA methylation programs regulate CAR T-cell exhaustion. The Journal of Immunology. 204(1_Supplement). 246.5–246.5. 5 indexed citations

14.

Vaidya, Abishek, Caitlin C. Zebley, Yiping Fan, et al.. (2019). Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia. Blood. 134(Supplement_1). 868–868. 1 indexed citations

15.

Lambert, Nathaniel D., Deanna Langfitt, Matthew L. Nilles, & David S. Bradley. (2011). Resistance to Yersinia pestis Infection Decreases with Age in B10.T(6R) Mice. Infection and Immunity. 79(11). 4438–4446. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact